Moderna
MRNA
#1261
Rank
A$21.81 B
Marketcap
$56.69
Share price
-0.94%
Change (1 day)
-52.87%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$21.81 Billion

As of November 2024 Moderna has a market cap of A$21.81 Billion. This makes Moderna the world's 1261th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024A$21.81 B-60.8%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Moderna was reported to be:

A$21.81 Billion
by Yahoo Finance info icon info icon
A$21.81 Billion
by CompaniesMarketCap info icon info icon
A$21.81 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.14 B-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$378.29 B 1,633.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.27 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.24 B 125.74%๐Ÿ‡บ๐Ÿ‡ธ USA
A$316.42 B 1,350.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.56 B-83.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$565.74 B 2,493.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.56 B-79.05%๐Ÿ‡บ๐Ÿ‡ธ USA